Translation-X

Translation-X is a biotech startup developing brain-penetrant MNK inhibitors to treat core symptoms of autism spectrum disorder. The company focuses on rare genetic conditions initially, using a phenotyping approach to expand its target population. Its novel therapeutic approach targets dysregulated mRNA translation to restore normal neural function.

+ 0 Upvotes
Buy Funded Startups lists